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M

ultiple endocrine neoplasia type 1 (MEN 1) is characterized by the combined occurrence of tumors of the pituitary gland and pancreatic islets and hyperplasia or adenomas of
the parathyroid glands. In 1988 the MEN 1 gene was mapped to
chromosome 11, and it was shown that in insulinomas oncogenesis involved a recessive mutation at this locus (1). A key
feature of MEN 1 is the multiple occurrence of tumors within the
affected glands. It is also possible to observe a complete spectmm of hyperplasia, microadenomas, adenomas, carcinomas,
and carcinoid changes on pathological examination of those affected glands (2).
In the Netherlands, with a population of 15 million, 20 families totaling about 200 patients with the MEN 1 syndrome have
been identified. Intensive screening programs have resulted in
identification of MEN 1 patients at an early age. The patients affected with MEN 1 tend to present with variable clinical pictures. The first manifestation of the disease is usually caused by
the hyperfunctioning of a single endocrine gland. Further progression results in hormonal hypersecretion by other glands resulting in a complex clinical syndrome. In this study we report
the results of screening and management of a large family in the
Netherlands.

Patients and Screening Procedures
The pedigree of family G is shown in the Figure. The following screening procedures have been performed annually since
1985.
Hyperparathyroidism
Fasting levels of creatinine, calcium, phosphorus, albumin,
and intact parathyroid hormone were measured. In selected patients 24-hour urinary calcium excretion and bone mass measurements were performed. Indications for parathyroid exploration in asymptomatic patients included the finding of a consistently elevated semm calcium level (> 11.4 mg/dL or 2.85
mmol/L), the presence of kidney stones, reduced creatinine
clearance, or reduced bone mass measurements. Parathyroid exploration was also performed in patients with bone, renal, gastrointestinal, or neuromuscular symptoms typical for primary
hyperparathyroidism. Imaging of the parathyroid glands priorto
initial neck exploration was considered unnecessary. The surgi-
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cal procedure performed was total parathyroidectomy and autologous transplantation to the forearm.
Pituitary gland
An elevation of serum prolactin concentrations on three separate days or from three sequential samples drawn from an indwelling cannula at 30-minute intervals was used to screen for
prolactinomas. If suspicion of overproduction of ACTH was
present, a low-dose dexamethasone suppression test or 24-hour
urine analysis for free Cortisol was utilized to screen for an
ACTH-producing adenoma. Insulin-like growth factor I and alpha subunits of follicle-stimulating hormone and cartilage-hair
hypoplasia were measured to screen for acromegaly or nonfunctioning adenomas.
Pancreatic islet cell tumors
Measurements of glucose, insulin (C-peptide), glucagon, gastrin, somatostatin, pancreatic polypeptide, and vasoactive intestinal peptide were performed to screen for pancreatic islet cell
tumors. Preoperative localization was performed by ultrasonography, computed tomography (CT), and, in specific cases, dynamic CT angiography and magnetic resonance imaging. Portal
venous sampling for peptide hormones produced was helpful in
determining specific hormone production by a tumor.

Results
In the G-family, 24 patients were identified as having the
MEN 1 syndrome (11 females and 13 males). The mean age at
which negative test results converted to positive was 14 years
(the youngest was 8 years old, the eldest 17 years old). The natural history of the MEN 1 syndrome in the G-family showed that
five patients died of MEN 1-related complications at a mean age
of 59 years. Death was caused by complications of peptic ulcer
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with metastases to the liver were seen in three males (111-2,4,9).
The entire spectrum of hyperplasia, microadenomas, and adenomas was demonstrated by pathological examination in all surgical .specimens.

Conclusions
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Figure—Pedigree ofthe G kindred.

disease, extensive metastases of pancreatic islet cell and/or endocrine gastrointestinal tumors, and renal failure due to hyperparathyroidism (HPT).
Hyperparathyroidism
Eighteen patients had HPT; 12 patients had surgery: six females (11-14, ni-5,16,28,29, V-7) and six males (II-6,111-3,4,9,
IV-7,9). Four patients (11-14,111-3,4,9) were operated on more
than once; one patient (III-9) was operated on three times. Two
proven MEN 1 patients (III-2, V-12) had no HPT symptoms or
signs. The eariiest diagnosis of HPT was in a boy at the age of 10
years (V-9).
Pituitary adenomas
Pituitary adenomas were found in five patients (II-1,111-4,9,
IV-7, V-12). A prolactinoma was diagnosed in three males who
have done well on oral bromocriptine (III-9, IV-7, V-12). The
youngest patient having a microprolactinoma was 14 years old.
A large nonfunctioning adenoma was found in one patient (III4).
Pancreatic islet cell tumors
Fifteen patients had pancreatic islet cell tumors (seven females and eight males). A boy aged 14 years with hypoglycemia
symptoms was operated on for insulinoma (V-12). Five of the
males (11-2,6,111-3,4,9) and one female (II-l) had gastrin-producing endocrine tumors resulting in the Zollinger-Ellison syndrome. Nonsymptomatic hyperplasia or adenomas were seen in
six females and three males. Pancreatic islet cell carcinomas
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In the past, complications of peptic ulcer disease were the
most common causes of death among untreated MEN 1 patients
(3,4). Other reported causes of death have been complications
related to hypoglycemia, disseminated carcinomatosis, renal
failure secondary to HPT, electrolyte imbalance secondary to
intractable diarrhea, pituitary insufficiency, and complications
of pancreatic and pituitary surgery.
Most patients (10 females and eight males) had HPT and 12
(six females and six males) underwent surgery. Four had more
than one operation.
We observed five patients with pituitary adenomas (one female and four males). Three patients had prolactin-secreting pituitary adenomas.
Pancreatic islet cell tumors were detected in 15 patients (one
insulinoma, six gastrinomas, and eight nonsymptomatic tumors).
Periodic examination of MEN 1 families promotes early diagnosis and treatment. Screening of families may improve the
prognosis by facilitating appropriate and timely management
decisions.
The prognosis of MEN 1 patients depends on several other
factors: the stage of the disease at thetimeof diagnosis, the aggressiveness of tumor growth, and the quality of diagnostic and
therapeutic procedures.
Clear oral and written information must be provided to the
family about clinical symptoms and signs, complications, treatment, prognosis, and inheritance of the syndrome. In addition,
information obtained from DNA linkage studies is useful becau.se such studies may help to establish predisposition for the
disease (5). In the near future, the MEN 1 gene will likely be
identified and DNA diagnosis of gene carrier status in a single
patient will be possible. However, aside from the biochemical
questions, the ethical and legal problems of predictive tests have
to be resolved.
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